|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 11734208.9 (espacenet) (Federated) (European Patent Register), 20110630 | Patent/reg. no. and date | DK/EP 2593429, 20150603 | Publication date | 20130522 | Priority no. and date | US 363725 P, 20100713 | EP pub. no. and date |
EP 2593429 20130522 | Effective date | | Applicant/owner | Theravance Biopharma R&D IP, LLC, 901 Gateway Boulevard
South San Francisco, CA 94080, US | Applicant ref. no. | P3904DKEP | Inventor | COLSON, Pierre-Jean, 301 Bryant Street 403
San Francisco California 94107, US | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | Opponent | | IPC Class | C07D 211/46 (2006.01) | Title | Fremgangsmåde til fremstilling af en biphenyl-2-ylcarbaminsyre | Int. application no. | US2011042530 | Int. publication no. | WO2012009166 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |